Biosimilar Newsletter Archive

31. 02.02.19 -- Employers & Biosimilars: Closing The Gap
    2/2/2019
    02/02/19 Biosimilar Development Newsletter
32. 01.31.19 -- Experts Discuss Biggest 2019 Biosimilar Challenges
    1/31/2019
    01/31/19 Biosimilar Development Newsletter
33. 01.24.19 -- 2018: The Year Of Biosimilar Real-World Evidence
    1/24/2019
    01/24/19 Biosimilar Development Newsletter
34. 01.17.19 -- How Will The FDA Shutdown Impact Pharma?
    1/17/2019
    01/17/19 Biosimilar Development Newsletter
35. 01.16.19 -- Raw Material Management: Working Together To Overcome Variability
    1/16/2019
    01/16/19 Biosimilar Development Newsletter
36. 01.10.19 -- Top 5 Biosimilar Developments Of 2018
    1/10/2019
    01/10/19 Biosimilar Development Newsletter
37. 01.03.19 -- What Biosimilar Metamorphases Are In Store For 2019?
    1/3/2019
    01/03/19 Biosimilar Development Newsletter
38. 12.20.18 -- How Did 2018 Impact Biosimilar Market Expectations?
    12/20/2018
    12/20/18 Biosimilar Development Newsletter
39. 12.18.18 -- Biosimilar Development Top 10 Of 2018
    12/18/2018
    12/18/18 Biosimilar Development Newsletter
40. 12.15.18 -- Embracing Uncertainty By Bringing Optionality Into Facility And Capacity Planning
    12/15/2018
    12/15/18 Biosimilar Development Newsletter